AgeChem Venture Fund
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting
Business Model:
Revenue: $2.5M
Employees: 2-10
Rankings
Industries / Tags:
Detailed AgeChem Venture Fund Information
Geographic Data
Address: 1 Westmount Square
City: Montreal
State: quebec
Zip: H3Z 2P9
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$44M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.
Contact Phone:
+15148497696
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 11/2012 | Alethia BioTherapeutics | Series B | 0 |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 1/2008 | Sonexa Therapeutics | Series A | 0 |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 9/2010 | Alethia BioTherapeutics | Series A | 0 |
| 2/2010 | Altair Therapeutics | Series B | 17M |
| 9/2011 | Medicago | Post-IPO Equity | 0 |
| 11/2009 | Advitech | Venture Round | 2.5M |
| 4/2011 | Akebia Therapeutics | Series B | 0 |
| 5/2014 | Sorbent Therapeutics | Series D | 0 |
| 6/2011 | Sorbent Therapeutics | Series B | 0 |
| 10/2007 | Chlorion Pharma | Venture Round | 6M |
| 2/2008 | Ocera Therapeutics | Series C | 0 |
| 9/2010 | Sorbent Therapeutics | Series B | 0 |
| 5/2014 | Sorbent Therapeutics | Series D | 0 |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 11/2012 | Alethia BioTherapeutics | Series B | 0 |
| 9/2011 | Medicago | Post-IPO Equity | 0 |
| 6/2011 | Sorbent Therapeutics | Series B | 0 |
| 4/2011 | Akebia Therapeutics | Series B | 0 |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 9/2010 | Sorbent Therapeutics | Series B | 0 |
| 9/2010 | Alethia BioTherapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
